Optimal time on HAART for prevention of mother-to-child transmission of HIV.
about
Antiretroviral drug regimens to prevent mother-to-child transmission of HIV: a review of scientific, program, and policy advances for sub-Saharan AfricaPoint-of-care CD4 testing to inform selection of antiretroviral medications in south african antenatal clinics: a cost-effectiveness analysisDetectable Viral Load in Late Pregnancy among Women in the Rwanda Option B+ PMTCT Program: Enrollment Results from the Kabeho StudyHIV monoclonal antibodies: a new opportunity to further reduce mother-to-child HIV transmissionEffects of valacyclovir on markers of disease progression in postpartum women co-infected with HIV-1 and herpes simplex virus-2Underutilisation of routinely collected data in the HIV programme in Zambia: a review of quantitatively analysed peer-reviewed articles.Pooled individual data analysis of 5 randomized trials of infant nevirapine prophylaxis to prevent breast-milk HIV-1 transmission.Patient factors to target for elimination of mother-to-child transmission of HIV.Predictors of unknown HIV serostatus at the time of labor and delivery in Kampala, Uganda.Disengagement of HIV-positive pregnant and postpartum women from antiretroviral therapy services: a cohort study.Systemic delays in the initiation of antiretroviral therapy during pregnancy do not improve outcomes of HIV-positive mothers: a cohort studyCommunity-based evaluation of PMTCT uptake in Nyanza Province, Kenya.Predictive factors of plasma HIV suppression during pregnancy: a prospective cohort study in Benin.Low rates of mother-to-child HIV transmission in a routine programmatic setting in Lilongwe, Malawi.Evaluation of a quality improvement intervention to prevent mother-to-child transmission of HIV (PMTCT) at Zambia defence force facilities.Syphilis in HIV-infected mothers and infants: results from the NICHD/HPTN 040 study.Early Initiation of ARV During Pregnancy to Move towards Virtual Elimination of Mother-to-Child-Transmission of HIV-1 in Yunnan, ChinaEarly infant diagnosis of HIV infection in Zambia through mobile phone texting of blood test results.Evolution of antiretroviral therapy services for HIV-infected pregnant women in Cape Town, South AfricaA New Look at Care in Pregnancy: Simple, Effective Interventions for Neglected Populations[Study of risk factors for HIV transmission from mother to child in the strategy «option A» in Lubumbashi, Democratic Republic of Congo]Option B+ for prevention of vertical HIV transmission has no influence on adverse birth outcomes in a cross-sectional cohort in Western Uganda.Contraceptive use and associated factors among women enrolling into HIV care in southwestern UgandaIntegrating antiretroviral therapy into antenatal care and maternal and child health settings: a systematic review and meta-analysis."They told me to come back": women's antenatal care booking experience in inner-city Johannesburg.Loss to follow-up before and after delivery among women testing HIV positive during pregnancy in Johannesburg, South AfricaAcceptability and Feasibility of a Mobile Phone-Based Case Management Intervention to Retain Mothers and Infants from an Option B+ Program in Postpartum HIV Care.Timing of maternal HIV testing and uptake of prevention of mother-to-child transmission interventions among women and their infected infants in Johannesburg, South Africa.The glory of guidelines and the twilight of reality: controversies and challenges in the prevention and treatment of HIV in children.Reproductive and maternal healthcare needs of HIV infected women.State of the art syphilis diagnostics: rapid point-of-care tests.The challenge of referring HIV-positive pregnant women with treatment indication from PMTCT to ART services: a retrospective follow-up study in Mbeya, Tanzania.Low mother-to-child HIV transmission rate but high loss-to-follow-up among mothers and babies in Mandalay, Myanmar; a cohort study.Perspectives on safer conception practices and preconception counseling among women living with HIV.Low prevalence of renal dysfunction in HIV-infected pregnant women: implications for guidelines for the prevention of mother-to-child transmission of HIV.Pilot programme for the rapid initiation of antiretroviral therapy in pregnancy in Cape Town, South Africa.Optimizing prevention of HIV mother to child transmission: Duration of antiretroviral therapy and viral suppression at delivery among pregnant Malawian women.Same-day antiretroviral therapy (ART) initiation in pregnancy is not associated with viral suppression or engagement in care: A cohort study.
P2860
Q27014960-F07DFB56-B836-4329-95D5-C399170E5A5AQ28543954-56501883-9D58-4A44-A732-C3BB265C22B3Q28555187-523AFF2B-D667-424F-9A1E-F0390F552B40Q28660329-11A1D9D9-9C52-4B0B-AFFF-E6252C79AD18Q28728582-888B228E-628C-4C71-87E6-4A7CCF456CCFQ30491997-A7986F0A-7319-4C2E-BBA2-FDD62B2EA287Q30569674-3DBF7D4B-5DFC-4217-8D9B-34A0310F47B1Q33631671-76F168A5-6D38-4791-BAE6-AD11AAEE3ABBQ34000706-20CF028B-7C2C-414C-9E69-959CA085B884Q34318914-69BBFB12-AC2D-40C8-9BA7-372CDD2A75F7Q34410294-7A1186B3-43F7-4143-A915-F9700756CD34Q34434132-1A5FC3A5-16A7-4F56-9432-96D73C937B16Q34649171-ED260D00-D949-41FF-8D7A-FC39B49EF200Q34761065-A368EA45-3EF5-4D2A-90AB-90BD627209CBQ34980431-46027719-3644-4760-A3D8-05054BB41A55Q35156725-051B5CAC-F04F-45F7-B72A-58AC3FC40D96Q35788503-EC245F16-6035-4ED2-8F05-1986181EDF58Q35926612-5A6C2AC6-0900-4014-A743-B1EA5AFA1642Q35998500-476777ED-4AD8-4A29-AC5F-F2546EE78438Q36106833-A56E1A5A-14FD-43BC-B606-4424F5E2DC16Q36284041-9377C377-B177-4D50-B71B-DD26DFCAE920Q36300046-2C35F725-B0C8-48B8-8AC1-E412832C05D8Q36311239-2F75F857-C2C9-474D-9A46-6561FED4FE13Q36509413-5DE5315A-EEC6-47A4-8820-3BF1AF552582Q36654965-9D8911C8-9EED-4F85-AA7B-007AA1747204Q36691692-EC94164C-53BC-4BC2-B294-90ACDE5D4D54Q36912148-A7C43EC2-3451-421C-A541-CB9149A08F34Q37723043-4B9F1B87-9F7A-4393-80D4-7E7203AF61A8Q38040150-BFDCE5F1-7FCC-4589-8089-D6366E9AF933Q38126891-5180027D-CBED-455F-84FC-09D2F69B664AQ38168931-9B48CFFB-D5A5-4906-8086-7D9874E129C0Q39520509-1E7032E2-6A22-4847-BD35-BCD0AFB270D8Q40060234-F508E364-AA28-4DE5-A0E1-DF0B885CFF35Q40941013-2F4FA275-5FF2-412A-BF10-D7A8C8355D7EQ42245194-E3C98687-5930-4CE3-8E97-6F1CE956CD98Q46278929-AE87D2E0-F058-4A3B-BCE8-969AAF30C2C1Q52610191-6C094BAD-96BA-4A02-BD6A-2FA5D3F2D107Q55361139-F29B4841-B7A9-46F8-8435-BCFDD51FC083
P2860
Optimal time on HAART for prevention of mother-to-child transmission of HIV.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Optimal time on HAART for prevention of mother-to-child transmission of HIV.
@ast
Optimal time on HAART for prevention of mother-to-child transmission of HIV.
@en
type
label
Optimal time on HAART for prevention of mother-to-child transmission of HIV.
@ast
Optimal time on HAART for prevention of mother-to-child transmission of HIV.
@en
prefLabel
Optimal time on HAART for prevention of mother-to-child transmission of HIV.
@ast
Optimal time on HAART for prevention of mother-to-child transmission of HIV.
@en
P2093
P2860
P1476
Optimal time on HAART for prevention of mother-to-child transmission of HIV.
@en
P2093
Benjamin H Chi
Benjamin J Dorton
Carla J Chibwesha
Elizabeth M Stringer
Jeffrey S A Stringer
Jessica Mulindwa
Mark J Giganti
Namwinga Chintu
Nande Putta
P2860
P304
P356
10.1097/QAI.0B013E318229147E
P407
P577
2011-10-01T00:00:00Z